Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$36.9M
+14.4% from 2023
Prescriptions
23K
$1,633.11 per claim
Patients
4,086
1,208 prescribers
Total spending, 2024
$36.9M
$9,020.02 per patient
Medicare prescription drug plans paid $36.9M for Amjevita(Cf) Autoinjector in 2024, for 22,569 prescriptions and refills to 4,086 patients (up 14.4% from 2023). The average cost per claim was $1,633.11.
California had the highest Medicare cost for Amjevita(Cf) Autoinjector in 2024: $16.6M for 11,767 claims, followed by Puerto Rico ($2.4M).
Jorge A Mundo, rheumatology in Humacao, PR, had the highest Medicare cost for Amjevita(Cf) Autoinjector in 2024: 200 claims costing $552K.
Amjevita(Cf) Autoinjector is made by Amgen Inc. (AMGN), listed in the Medicare spending data as Amgen, Amgen USA Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jorge A Mundo Humacao, PR | Rheumatology | 200 | 34 | $552K |
| Khashayar Khosraviani Santa Rosa, CA | Rheumatology | 150 | 44 | $348K |
| Miten Vasa |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 917 | 13,582 | 2,695 | $32.2M |
| 2024 | 1,208 | 22,569 | 4,086 | $36.9M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 167 |
| 42 |
| $309K |
| Ann Trout Hyannis, MA | Rheumatology | 95 | 13 | $308K |
| Brian L Greenberg Portland, OR | Rheumatology | 199 | 38 | $291K |
| Vandana Khurma Cincinnati, OH | Rheumatology | 162 | 35 | $283K |
| Payal Suthar Duluth, GA | Rheumatology | 237 | 43 | $271K |
| Michelle L Chu Modesto, CA | Rheumatology | 103 | 41 | $257K |
| Kalonji Collins Halethorpe, MD | Internal Medicine | 240 | 34 | $250K |
| Antony T Lin Fontana, CA | Internal Medicine | 222 | 38 | $243K |
| Sharon M Ing Riverside, CA | Internal Medicine | 152 | 44 | $243K |
| Joey Kim Sacramento, CA | Rheumatology | 86 | 26 | $238K |
| Khin Sandar Lim Wildomar, CA | Internal Medicine | 193 | 42 | $238K |
| Ola M Azzouqah Albuquerque, NM | Rheumatology | 75 | Under 11 | $235K |
| Joseph J Martin San Diego, CA | Internal Medicine | 157 | 44 | $233K |
| Virginia C Chan Bellflower, CA | Internal Medicine | 148 | 25 | $217K |
| Ricardo Bardales Mendoza Anaheim, CA | Internal Medicine | 166 | 33 | $215K |
| Anupama S Bhat Roseville, CA | Rheumatology | 103 | 30 | $211K |
| Karen M Au Los Angeles, CA | Internal Medicine | 163 | 31 | $208K |
| Michiko Inaba Honolulu, HI | Rheumatology | 144 | 29 | $200K |
| Kasey L Flores Roseville, CA | Pharmacist | 129 | 40 | $200K |
| Chandrahasa Annem Albuquerque, NM | Rheumatology | 78 | Under 11 | $199K |
| Jonathan Hu Oakland, CA | Pharmacist | 105 | 21 | $199K |
| Amy C Chang Riverside, CA | Rheumatology | 129 | 39 | $199K |
| Christine A McBurney Portland, OR | Rheumatology | 129 | 30 | $199K |
| Spending |
|---|
| Amgen AMGN | 16,947 | $23.0M |
| Amgen USA Inc. AMGN | 5,641 | $13.9M |